Skip to content


Peptyde Bio Closes Oversubscribed Pre-Seed Round

November 15, 2022

St. Louis, MO (November 15, 2022) – Peptyde Bio Inc. announced that it has closed an oversubscribed $1.2M pre-seed funding round. Peptyde Bio is the first company spun out of the Donald Danforth Plant Science Center by Danforth Technology Company (DTC), the wholly-owned subsidiary formed by the Danforth Center in February 2022.